| |
有關代理材料供應的重要通知
虛擬股東年會 to Be Held on Tuesday, May 24, 2022 at 8:00 a.m. Central Time.
註冊參加虛擬年會
通過http://viewproxy.com/markertherapeutics/2022/htype.asp.
股東的委託書和年度報告可在
上查閲
http://www.viewproxy.com/markertherapeutics/2022. |
| |
| |
誠摯邀請您參加虛擬年會。您將不能親自出席年會。無論您是否預期出席會議,請儘快填寫、註明日期、簽署並寄回隨附的委託書,或按照這些材料的指示通過電話或互聯網投票,以確保您出席會議。為了您的方便,我們提供了一個回郵信封(如果在美國郵寄,則預付郵資)。即使你已經通過代理投票,如果你參加了虛擬年會,你仍然可以在線投票。然而,請注意,如果您的股票由經紀人、銀行或其他代名人登記持有,並且您希望在會議上投票,您必須從該記錄持有人那裏獲得以您的名義簽發的委託書。
|
| |
| | |
Page
|
|
有關這些代理材料和投票的問答
|
| |
1
|
|
提案1董事選舉
|
| |
9
|
|
有關董事會和公司治理的信息
|
| |
13
|
|
關於高管薪酬的提案2諮詢投票
|
| |
19
|
|
建議3修改公司的公司註冊證書,以增加普通股的法定股數
|
| |
20
|
|
PROPOSALS 4 AND 5 BACKGROUND
|
| |
21
|
|
提案4反向股票拆分提案
|
| |
22
|
|
提案5授權股份減持提案
|
| |
31
|
|
建議6批准經修訂的公司2020年股權激勵計劃,將授權發行的股票數量增加850萬股
|
| |
34
|
|
提案7批准選擇獨立註冊會計師事務所
|
| |
48
|
|
EXECUTIVE OFFICERS
|
| |
49
|
|
某些受益所有者和管理層的擔保所有權
|
| |
51
|
|
第16(A)節欠款報告
|
| |
53
|
|
高管薪酬
|
| |
54
|
|
董事薪酬
|
| |
61
|
|
與關聯人的交易及賠償
|
| |
63
|
|
代理材料入庫
|
| |
65
|
|
OTHER MATTERS
|
| |
66
|
|
| |
互聯網代理投票允許您在線投票您的股票,其程序旨在確保您的代理投票指令的真實性和正確性。但是,請注意,您必須承擔與您的互聯網接入相關的任何費用,例如互聯網接入提供商和電話公司的使用費。
|
| |
| |
Board Diversity Matrix (as of April 1, 2022)
|
| | ||||||||
| | 導演總數 | | | |
8
|
| | ||||
| | | | | |
Female
|
| | |
Male
|
| |
| |
Part I: Gender Identity
|
| | | | | | | | | |
| |
Directors
|
| | |
1
|
| | |
7
|
| |
| |
第二部分:人口統計背景
|
| | | | | | | | | |
| |
Asian
|
| | |
—
|
| | |
1
|
| |
| |
Hispanic or Latinx
|
| | |
—
|
| | |
1
|
| |
| |
White
|
| | |
1
|
| | |
4
|
| |
| |
兩個或多個種族或民族
|
| | |
—
|
| | |
1
|
| |
Name
|
| |
Audit
|
| |
Compensation
|
| |
Nominating and
Corporate Governance |
| |||||||||
David Eansor | | | | | X* | | | | | | | | | | | | X | | |
Steven Elms | | | | | X | | | | | | X | | | | | | | | |
Peter Hoang | | | | | | | | | | | | | | | | | | | |
Katharine Knobil | | | | | | | | | | | | | | | | | | | |
David Laskow-Pooley | | | | | X | | | | | | X* | | | | | | | | |
Frederick Wasserman** | | | | | X | | | | | | X | | | | | | X | | |
Juan Vera | | | | | | | | | | | | | | | | | | | |
John Wilson | | | | | | | | | | | | | | | | | X* | | |
Total meetings in fiscal 2021 | | | | | 4 | | | | | | 4 | | | | | | 4 | | |
Status
|
| |
Number of
Shares of Common Stock Authorized |
| |
Number of
Shares of Common Stock Issued and Outstanding |
| |
Number of
Shares of Common Stock Reserved for Future Issuance |
| |
Number of
Shares of Common Stock Authorized but Unissued and Unreserved |
| ||||||||||||
反向股票拆分前 | | | | | 300,000,000 | | | | | | 83,451,187 | | | | | | 30,079,613 | | | | | | 186,469,200 | | |
Post-Reverse Stock Split 1:3 | | | | | 100,000,000 | | | | | | 27,817,062 | | | | | | 10,026,538 | | | | | | 62,156,400 | | |
Post-Reverse Stock Split 1:4 | | | | | 75,000,000 | | | | | | 20,862,797 | | | | | | 7,519,903 | | | | | | 46,617,300 | | |
Post-Reverse Stock Split 1:5 | | | | | 60,000,000 | | | | | | 16,690,237 | | | | | | 6,015,923 | | | | | | 37,293,840 | | |
Post-Reverse Stock Split 1:6 | | | | | 50,000,000 | | | | | | 13,908,531 | | | | | | 5,013,269 | | | | | | 31,078,200 | | |
Post-Reverse Stock Split 1:7 | | | | | 42,857,143 | | | | | | 11,921,598 | | | | | | 4,297,088 | | | | | | 26,638,457 | | |
Post-Reverse Stock Split 1:8 | | | | | 37,500,000 | | | | | | 10,431,398 | | | | | | 3,759,952 | | | | | | 23,308,650 | | |
Post-Reverse Stock Split 1:9 | | | | | 33,333,333 | | | | | | 9,272,354 | | | | | | 3,342,179 | | | | | | 20,718,800 | | |
Post-Reverse Stock Split 1:10 | | | | | 30,000,000 | | | | | | 8,345,119 | | | | | | 3,007,961 | | | | | | 18,646,920 | | |
Post-Reverse Stock Split 1:11 | | | | | 27,272,727 | | | | | | 7,586,472 | | | | | | 2,734,510 | | | | | | 16,951,745 | | |
Post-Reverse Stock Split 1:12 | | | | | 25,000,000 | | | | | | 6,954,266 | | | | | | 2,506,634 | | | | | | 15,539,100 | | |
Status
|
| |
Number of
Shares of Common Stock Authorized |
| |
Number of
Shares of Common Stock Issued and Outstanding |
| |
Number of
Shares of Common Stock Reserved for Future Issuance |
| |
Number of
Shares of Common Stock Authorized but Unissued and Unreserved |
| ||||||||||||
反向股票拆分前 | | | | | 150,000,000 | | | | | | 83,451,187 | | | | | | 30,079,613 | | | | | | 36,469,200 | | |
Post-Reverse Stock Split 1:3 | | | | | 50,000,000 | | | | | | 27,817,062 | | | | | | 10,026,538 | | | | | | 12,156,400 | | |
Post-Reverse Stock Split 1:4 | | | | | 37,500,000 | | | | | | 20,862,797 | | | | | | 7,519,903 | | | | | | 9,117,300 | | |
Post-Reverse Stock Split 1:5 | | | | | 30,000,000 | | | | | | 16,690,237 | | | | | | 6,015,923 | | | | | | 7,293,840 | | |
Post-Reverse Stock Split 1:6 | | | | | 25,000,000 | | | | | | 13,908,531 | | | | | | 5,013,269 | | | | | | 6,078,200 | | |
Post-Reverse Stock Split 1:7 | | | | | 21,428,571 | | | | | | 11,921,598 | | | | | | 4,297,088 | | | | | | 5,209,886 | | |
Post-Reverse Stock Split 1:8 | | | | | 18,750,000 | | | | | | 10,431,398 | | | | | | 3,759,952 | | | | | | 4,558,650 | | |
Post-Reverse Stock Split 1:9 | | | | | 16,666,667 | | | | | | 9,272,354 | | | | | | 3,342,179 | | | | | | 4,052,133 | | |
Post-Reverse Stock Split 1:10 | | | | | 15,000,000 | | | | | | 8,345,119 | | | | | | 3,007,961 | | | | | | 3,646,920 | | |
Post-Reverse Stock Split 1:11 | | | | | 13,636,364 | | | | | | 7,586,472 | | | | | | 2,734,510 | | | | | | 3,315,382 | | |
Post-Reverse Stock Split 1:12 | | | | | 12,500,000 | | | | | | 6,954,266 | | | | | | 2,506,634 | | | | | | 3,039,100 | | |
Status
|
| |
Number of
Shares of Common Stock Authorized |
| |
Number of
Shares of Common Stock Issued and Outstanding |
| |
Number of
Shares of Common Stock Reserved for Future Issuance |
| |
Number of
Shares of Common Stock Authorized but Unissued and Unreserved |
| ||||||||||||
反向股票拆分前 | | | | | 300,000,000 | | | | | | 83,451,187 | | | | | | 30,079,613 | | | | | | 186,469,200 | | |
Post-Reverse Stock Split 1:3 | | | | | 300,000,000 | | | | | | 27,817,062 | | | | | | 10,026,538 | | | | | | 262,156,400 | | |
Post-Reverse Stock Split 1:4 | | | | | 300,000,000 | | | | | | 20,862,797 | | | | | | 7,519,903 | | | | | | 271,617,300 | | |
Post-Reverse Stock Split 1:5 | | | | | 300,000,000 | | | | | | 16,690,237 | | | | | | 6,015,923 | | | | | | 277,293,840 | | |
Post-Reverse Stock Split 1:6 | | | | | 300,000,000 | | | | | | 13,908,531 | | | | | | 5,013,269 | | | | | | 281,078,200 | | |
Post-Reverse Stock Split 1:7 | | | | | 300,000,000 | | | | | | 11,921,598 | | | | | | 4,297,088 | | | | | | 283,781,314 | | |
Post-Reverse Stock Split 1:8 | | | | | 300,000,000 | | | | | | 10,431,398 | | | | | | 3,759,952 | | | | | | 285,808,650 | | |
Post-Reverse Stock Split 1:9 | | | | | 300,000,000 | | | | | | 9,272,354 | | | | | | 3,342,179 | | | | | | 287,385,467 | | |
Post-Reverse Stock Split 1:10 | | | | | 300,000,000 | | | | | | 8,345,119 | | | | | | 3,007,961 | | | | | | 288,646,920 | | |
Post-Reverse Stock Split 1:11 | | | | | 300,000,000 | | | | | | 7,586,472 | | | | | | 2,734,510 | | | | | | 289,679,018 | | |
Post-Reverse Stock Split 1:12 | | | | | 300,000,000 | | | | | | 6,954,266 | | | | | | 2,506,634 | | | | | | 290,539,100 | | |
Status
|
| |
Number of
Shares of Common Stock Authorized |
| |
Number of
Shares of Common Stock Issued and Outstanding |
| |
Number of
Shares of Common Stock Reserved for Future Issuance |
| |
Number of
Shares of Common Stock Authorized but Unissued and Unreserved |
| ||||||||||||
反向股票拆分前 | | | | | 150,000,000 | | | | | | 83,451,187 | | | | | | 30,079,613 | | | | | | 36,469,200 | | |
Post-Reverse Stock Split 1:3 | | | | | 150,000,000 | | | | | | 27,817,062 | | | | | | 10,026,538 | | | | | | 112,156,400 | | |
Post-Reverse Stock Split 1:4 | | | | | 150,000,000 | | | | | | 20,862,797 | | | | | | 7,519,903 | | | | | | 121,617,300 | | |
Post-Reverse Stock Split 1:5 | | | | | 150,000,000 | | | | | | 16,690,237 | | | | | | 6,015,923 | | | | | | 127,293,840 | | |
Post-Reverse Stock Split 1:6 | | | | | 150,000,000 | | | | | | 13,908,531 | | | | | | 5,013,269 | | | | | | 131,078,200 | | |
Post-Reverse Stock Split 1:7 | | | | | 150,000,000 | | | | | | 11,921,598 | | | | | | 4,297,088 | | | | | | 133,781,314 | | |
Post-Reverse Stock Split 1:8 | | | | | 150,000,000 | | | | | | 10,431,398 | | | | | | 3,759,952 | | | | | | 135,808,650 | | |
Post-Reverse Stock Split 1:9 | | | | | 150,000,000 | | | | | | 9,272,354 | | | | | | 3,342,179 | | | | | | 137,385,467 | | |
Post-Reverse Stock Split 1:10 | | | | | 150,000,000 | | | | | | 8,345,119 | | | | | | 3,007,961 | | | | | | 138,646,920 | | |
Post-Reverse Stock Split 1:11 | | | | | 150,000,000 | | | | | | 7,586,472 | | | | | | 2,734,510 | | | | | | 139,679,018 | | |
Post-Reverse Stock Split 1:12 | | | | | 150,000,000 | | | | | | 6,954,266 | | | | | | 2,506,634 | | | | | | 140,539,100 | | |
反向股票拆分比率
|
| |
Number of Shares of
Common Stock Authorized |
| |||
無(當前,如果提案3獲得批准) | | | | | 300,000,000 | | |
Post-Reverse Stock Split 1:3 | | | | | 100,000,000 | | |
Post-Reverse Stock Split 1:4 | | | | | 75,000,000 | | |
Post-Reverse Stock Split 1:5 | | | | | 60,000,000 | | |
Post-Reverse Stock Split 1:6 | | | | | 50,000,000 | | |
Post-Reverse Stock Split 1:7 | | | | | 42,857,143 | | |
Post-Reverse Stock Split 1:8 | | | | | 37,500,000 | | |
Post-Reverse Stock Split 1:9 | | | | | 33,333,333 | | |
Post-Reverse Stock Split 1:10 | | | | | 30,000,000 | | |
Post-Reverse Stock Split 1:11 | | | | | 27,272,727 | | |
Post-Reverse Stock Split 1:12 | | | | | 25,000,000 | | |
反向股票拆分比率
|
| |
Number of Shares of
Common Stock Authorized |
| |||
無(當前,如果提案3未獲批准) | | | | | 150,000,000 | | |
Post-Reverse Stock Split 1:3 | | | | | 50,000,000 | | |
Post-Reverse Stock Split 1:4 | | | | | 37,500,000 | | |
Post-Reverse Stock Split 1:5 | | | | | 30,000,000 | | |
Post-Reverse Stock Split 1:6 | | | | | 25,000,000 | | |
Post-Reverse Stock Split 1:7 | | | | | 21,428,571 | | |
Post-Reverse Stock Split 1:8 | | | | | 18,750,000 | | |
Post-Reverse Stock Split 1:9 | | | | | 16,666,667 | | |
Post-Reverse Stock Split 1:10 | | | | | 15,000,000 | | |
Post-Reverse Stock Split 1:11 | | | | | 13,636,364 | | |
Post-Reverse Stock Split 1:12 | | | | | 12,500,000 | | |
| | |
As of
March 25, 2022 |
| |||
受已發行股票期權約束的普通股股份總數 | | | | | 9,404,047 | | |
已發行股票期權加權平均每股行權價 | | | | $ | 4.54 | | |
加權-已發行股票期權的平均剩餘期限(年) | | | | | 7.9 | | |
獲得全額獎勵的普通股股份總數 | | | | | 0 | | |
2014年計劃可供授予的普通股總股數(1) | | | | | 0 | | |
2020年計劃可供轉讓的股份總數 | | | | | 845,981 | | |
已發行普通股總股數 | | | | | 83,451,187 | | |
納斯達克全球市場公佈的普通股每股收盤價 | | | | $ | 0.5238 | | |
Key Equity Metrics
|
| |
2019
|
| |
2020
|
| |
2021
|
| |||||||||
Burn Rate(1) | | | | | 2.6% | | | | | | 3.3% | | | | | | 2.5% | | |
Overhang(2) | | | | | 16.4% | | | | | | 21.1% | | | | | | 12.8% | | |
Dilution(3) | | | | | 10.9% | | | | | | 11.8% | | | | | | 9.3% | | |
Name and position
|
| |
Number of shares(1)
|
| |||
總裁兼首席執行官Peter Hoang | | | | | — | | |
首席財務官Anthony Kim | | | | | — | | |
首席醫療官Mythili Koneru | | | | | — | | |
所有現任高管作為一個羣體 | | | | | — | | |
作為一個組,所有非執行主管的現任董事 | | | |
|
(2)
|
| |
作為一個羣體,所有現任員工,包括所有不是執行官員的現任官員
|
| | | | — | | |
Name and position
|
| |
Number of
shares |
| |||
總裁兼首席執行官Peter Hoang | | | | | 2,649,855 | | |
首席財務官Anthony Kim | | | | | 880,000 | | |
首席醫療官Mythili Koneru | | | | | 750,000 | | |
所有現任高管作為一個羣體 | | | | | 7,154,022 | | |
作為一個組,所有非執行主管的現任董事 | | | | | 187,500(1) | | |
每位董事候選人 | | | | | — | | |
任何董事的每位合夥人、高管或被提名人 | | | | | — | | |
根據2020年計劃獲得或將獲得5%權利的每個其他人 | | | | | — | | |
作為一個羣體,所有現任員工,包括所有不是執行官員的現任官員
|
| | | | 2,062,525 | | |
Plan Category
|
| |
Number of Securities
to be Issued Upon Exercise of Outstanding Options and Rights |
| |
Weighted-
Average Exercise Price of Outstanding Options and Rights |
| |
Number of Securities
Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) |
| |||||||||
股東批准的股權計劃 | | | | | 7,686,233(1) | | | | | $ | 5.47 | | | | | | 2,936,526(2) | | |
股東未批准股權計劃 | | | | | — | | | | | | — | | | | | | — | | |
Total | | | | | 7,686,233 | | | | | $ | 5.47 | | | | | | 2,936,526 | | |
| | |
Year Ended
December 31, |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Audit Fees(1) | | | | $ | 238,000 | | | | | $ | 185,400 | | |
Total Fees | | | | $ | 238,000 | | | | | $ | 185,400 | | |
Name
|
| |
Age
|
| |
Position(s)
|
|
Peter Hoang | | |
50
|
| | 總裁兼首席執行官兼董事 | |
Anthony Kim | | |
46
|
| | 首席財務官 | |
Juan Vera, M.D. | | |
42
|
| |
首席科學官、首席運營官兼董事
|
|
Mythili Koneru, M.D., Ph.D. | | |
44
|
| | | |
Michael Loiacono | | |
56
|
| | 首席會計官 | |
Nadia Agopyan, Ph.D. | | |
60
|
| | 監管事務副總裁 | |
Gerald Garrett | | |
57
|
| | 臨牀運營副總裁 | |
Tsvetelina Hoang, Ph.D. | | |
49
|
| | 研發部副總裁 | |
Anna Szymanska | | |
48
|
| | 質量副總裁 | |
|
Beneficial Owner
|
| |
Beneficial Ownership(1)
|
| |||||||||
|
Number of
Shares |
| |
Percent of Total
|
| |||||||||
| 5%或更多股東: | | | | | | | | | | | | | |
|
新企業助理(2)
|
| | | | 14,464,285 | | | | | | 17.4% | | |
|
Aisling Capital IV LP(3)
|
| | | | 4,642,857 | | | | | | 5.6% | | |
| 被任命的高管和董事: | | | | | | | | | | | | | |
|
Peter L. Hoang(4)
|
| | | | 1,918,076 | | | | | | 2.3% | | |
|
Anthony Kim(5)
|
| | | | 486,649 | | | | | | * | | |
|
Mythili Koneru(6)
|
| | | | 367,929 | | | | | | * | | |
|
David Eansor(7)
|
| | | | 49,440 | | | | | | * | | |
|
Steven Elms(8)
|
| | | | 4,685,037 | | | | | | 5.6% | | |
|
David Laskow-Pooley(9)
|
| | | | 67,723 | | | | | | * | | |
|
Dr. Juan Vera, M.D(10)
|
| | | | 3,845,209 | | | | | | 4.6% | | |
|
Frederick Wasserman(11)
|
| | | | 77,723 | | | | | | * | | |
|
John Wilson(12)
|
| | | | 10,022,450 | | | | | | 12.1% | | |
|
Katharine Knobil(13)
|
| | | | 15,388 | | | | | | * | | |
|
全體高管和董事(15人)(14人)
|
| | | | 22,608,919 | | | | | | 27.2% | | |
姓名和主要職務
|
| |
Year
|
| |
Salary
($) |
| |
Option
Awards ($)(1) |
| |
Non-Equity
Incentive Plan Compensation ($) |
| |
Total
($) |
| |||||||||||||||
Peter Hoang(2) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
President and Chief
|
| | | | 2021 | | | | | | 424,089 | | | | | | 1,001,900 | | | | | | 193,043(3) | | | | | | 1,619,032 | | |
Executive Officer
|
| | | | 2020 | | | | | | 416,882 | | | | | | 748,200 | | | | | | 209,000 | | | | | | 1,374,082 | | |
Anthony Kim | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
首席財務官
|
| | | | 2021 | | | | | | 400,754 | | | | | | 401,600 | | | | | | 145,937(3) | | | | | | 948,291 | | |
| | | 2020 | | | | | | 392,906 | | | | | | 278,400 | | | | | | 158,000 | | | | | | 829,306 | | | ||
Mythili Koneru | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Chief Medical Officer
|
| | | | 2021 | | | | | | 405,827 | | | | | | 351,400 | | | | | | 144,311 | | | | | | 901,538 | | |
| | | | | 2020 | | | | | | 398,600 | | | | | | 243,600 | | | | | | 140,000 | | | | | | 782,200 | | |
Name
|
| |
2021 Annual
Base Salary ($) |
| |
2020 Annual
Base Salary ($) |
| ||||||
Peter Hoang | | | | | 424,270 | | | | | | 418,000 | | |
Anthony Kim | | | | | 400,925 | | | | | | 395,000 | | |
Mythili Koneru | | | | | 406,000 | | | | | | 400,000 | | |
Name
|
| |
Restricted Stock
Units Grant In Lieu of 50% of Earned Annual Incentive Compensation (Number of Shares) |
| |
Grant Date Fair
Value ($)(1) |
| ||||||
Peter L. Hoang | | | | | 199,094 | | | | | | 96,521 | | |
Anthony Kim | | | | | 150,512 | | | | | | 72,968 | | |
| | |
Option Awards(1)
|
| |||||||||||||||||||||||||||
Name
|
| |
Grant Date
|
| |
Number of
Securities Underlying Unexercised Options (#) Exercisable |
| |
Number of
Securities Underlying Unexercised Options (#) Unexercisable(5) |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |||||||||||||||
Peter L. Hoang | | | | | 2/11/2021 | | | | | | 107,496 | | | | | | 322,504(2) | | | | | | 3.06 | | | | | | 2/11/2031 | | |
| | | | | 3/10/2020 | | | | | | 206,034 | | | | | | 223,966(2) | | | | | | 2.12 | | | | | | 3/10/2030 | | |
| | | | | 10/18/2018 | | | | | | 1,104,906 | | | | | | 198,287(2) | | | | | | 9.18 | | | | | | 10/19/2028 | | |
Anthony Kim | | | | | 2/10/2021 | | | | | | 39,996 | | | | | | 120,004(2) | | | | | | 3.29 | | | | | | 2/10/2031 | | |
| | | | | 3/10/2020 | | | | | | 76,659 | | | | | | 83,341(2) | | | | | | 2.12 | | | | | | 3/10/2030 | | |
| | | | | 11/27/2018 | | | | | | 333,328 | | | | | | 66,672(3) | | | | | | 6.81 | | | | | | 11/27/2028 | | |
Mythili Koneru | | | | | 2/10/2021 | | | | | | 35,004 | | | | | | 104,996(2) | | | | | | 3.29 | | | | | | 2/10/2031 | | |
| | | | | 3/10/2020 | | | | | | 67,091 | | | | | | 72,909(2) | | | | | | 2.12 | | | | | | 3/10/2030 | | |
| | | | | 2/7/2019 | | | | | | 10,000(4) | | | | | | — | | | | | | 5.10 | | | | | | 2/7/2029 | | |
| | | | | 2/7/2019 | | | | | | 225,000 | | | | | | 75,000(3) | | | | | | 5.10 | | | | | | 2/7/2029 | | |
Name(1)(2)
|
| |
Fees Earned or
Paid in Cash ($) |
| |
Stock Awards
($)(3) |
| |
Option Awards
($)(4) |
| |
Total
($) |
| ||||||||||||
David Eansor | | | | | 40,000 | | | | | | 39,999 | | | | | | — | | | | | | 79,999 | | |
Steven Elms | | | | | 40,000 | | | | | | 39,999 | | | | | | — | | | | | | 79,999 | | |
Katharine Knobil | | | | | 2,608(5) | | | | | | — | | | | | | 103,750 | | | | | | 106,358 | | |
David Laskow-Pooley | | | | | 40,000 | | | | | | 39,999 | | | | | | — | | | | | | 79,999 | | |
弗雷德裏克·沃瑟曼 | | | | | 40,000 | | | | | | 39,999 | | | | | | — | | | | | | 79,999 | | |
John Wilson | | | | | 40,000 | | | | | | 39,999 | | | | | | — | | | | | | 79,999 | | |
| | | | By: | | |
Peter Hoang
總裁兼首席執行官 |
|
By: |
|
| | |
Page
|
| |||
1. Gvbl.
|
| | | | C-1 | | |
2. S受該計劃約束的野兔
|
| | | | C-1 | | |
3. E可配合性和侷限性
|
| | | | C-2 | | |
4. O認購和股票增值權
|
| | | | C-3 | | |
5. A期權和股票增值權以外的其他權利
|
| | | | C-6 | | |
6. A普通股變動的調整;其他公司事項
|
| | | | C-7 | | |
7. A行政管理
|
| | | | C-9 | | |
8. TAX扣繳
|
| | | | C-11 | | |
9. M其他
|
| | | | C-11 | | |
10. C公司的權利人
|
| | | | C-14 | | |
11. S永恆性
|
| | | | C-14 | | |
12. T計劃的最終結果
|
| | | | C-14 | | |
13. D定義
|
| | | | C-14 | | |